Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.38 |
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | EEF2K | O00418 | 2/20 | 0.31 |
| ▸ | EEF2 | P13639 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | PLK4 | O00444 | 1/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | TYK2 | P29597 | 1/20 | 0.31 |
| ▸ | FLT3 | P36888 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ITK | Q08881 | 1/20 | 0.31 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL926779 | 0.92 | CA1 (0.31) | CA1CA2 | |
| SCHEMBL30773895 | 0.90 | CA1 (0.39) | CA1CA2 | |
| SCHEMBL6060060 | 0.87 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL707413 | 0.86 | KCNH2 (0.41) | CA1CA2EEF2KEEF2MEN1 | |
| Trifluoromethanesulfonic Acid SCHEMBL25275366 | 0.85 | CA1 (0.42) | CA1CA2EEF2KEEF2MEN1 | |
| Trifluoromethanesulfonic Acid SCHEMBL1329985 | 0.81 | CA1 (0.47) | CA1CA2EEF2KEEF2MEN1 | |
| Trifluoromethanesulfonic Acid SCHEMBL1329120 | 0.81 | CA1 (0.47) | CA1CA2EEF2KEEF2MEN1 | |
| Trifluoromethanesulfonic Acid SCHEMBL1330197 | 0.81 | CA1 (0.47) | CA1CA2EEF2KEEF2MEN1 | |
| Trifluoromethanesulfonic Acid SCHEMBL711975 | 0.81 | CA1 (0.47) | CA1CA2EEF2KEEF2MEN1 | |
| Sulfuric Acid SCHEMBL4247474 | 0.81 | CA1 (0.44) | CA1CA2EEF2KEEF2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2252672-B1 | COMPOSITION COMPRISING PHOTOCHROMIC DYES IN AN IONIC SOLVENT | ESSILOR INT (FR) | 2019-02-20 | — | — | EP | claimed |
| US-8411347-B2 | Composition comprising photochromic dyes in an ionic solvent | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2013-04-02 | — | — | US | claimed |
| EP-1698686-B1 | Co-Production of olefins and esters via ethenolysis of unsaturated fats in non-aqueous ionic liquids. | INST FRANCAIS DU PETROLE (FR) | 2012-11-07 | — | — | EP | claimed |
| US-20110013252-A1 | COMPOSITION COMPRISING PHOTOCHROMIC DYES IN AN IONIC SOLVENT | Essilor International (compagnie Generale D'optiqu e (FR) | 2011-01-20 | — | — | US | claimed |
| EP-1810961-B1 | Method of co-producing olefins and diesters or diacids by homometathesis of unsaturated fatty bodies in non-aqueous ionic liquids | INST FRANCAIS DU PETROLE (FR) | 2010-12-29 | — | — | EP | claimed |
| US-7754904-B2 | Process for co-producing olefins and diesters or diacids by homomethathesis of unsaturated fats in non-aqueous ionic liquids | INSTITUT FRANCAIS DU PETROLE (FR) | 2010-07-13 | — | — | US | claimed |
| US-7678932-B2 | Process for co-producing olefins and esters by ethenolysis of unsaturated fats in non-aqueous ionic liquids | INSTITUT FRANCAIS DU PETROLE (FR) | 2010-03-16 | — | — | US | claimed |
| US-20070179302-A1 | PROCESS FOR CO-PRODUCING OLEFINS AND DIESTERS OR DIACIDS BY HOMOMETHATHESIS OF UNSATURATED FATS IN NON-AQUEOUS IONIC LIQUIDS | INSTITUT FRANCAIS DU PETROLE (FR) | 2007-08-02 | — | — | US | claimed |
| US-20060079704-A1 | Process for co-producing olefins and esters by ethenolysis of unsaturated fats in non-aqueous ionic liquids | INSTITUT FRANCAIS DU PETROLE (FR) | 2006-04-13 | — | — | US | claimed |
| US-20060070919-A1 | Process for separating oxygen-containing compounds contained in a hydrocarbon feed, employing an ionic liquid | INSTITUT FRANCAIS DU PETROLE (FR) | 2006-04-06 | — | — | US | claimed |
| US-20230374230-A1 | CROSSLINKED GEL FORMULATION | ESSILOR INTERNATIONAL (FR) | 2023-11-23 | — | — | US | disclosed |
| WO-2022078935-A1 | CROSSLINKED GEL FORMULATION | ESSILOR INTERNATIONAL (FR) | 2022-04-21 | — | — | WO | disclosed |
| EP-3985046-A1 | CROSSLINKED GEL FORMULATION | ESSILOR INTERNATIONAL (FR) | 2022-04-20 | — | — | EP | disclosed |
| US-8411347-B2 | Composition comprising photochromic dyes in an ionic solvent | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2013-04-02 | — | — | US | disclosed |
| US-8039660-B2 | Method of producing nitrile compounds | RHODIA POLYAMIDE INTERMEDIATES (FR) | 2011-10-18 | — | — | US | disclosed |
| US-7060860-B2 | Hydroformylation process employing a cobalt-based catalyst in a non-aqueous liquid with improved catalyst recycling | INSTITUT FRANCAIS DU PETROLE (FR) | 2006-06-13 | — | — | US | disclosed |
| US-20060079704-A1 | Process for co-producing olefins and esters by ethenolysis of unsaturated fats in non-aqueous ionic liquids | INSTITUT FRANCAIS DU PETROLE (FR) | 2006-04-13 | — | — | US | disclosed |
| US-20060070919-A1 | Process for separating oxygen-containing compounds contained in a hydrocarbon feed, employing an ionic liquid | INSTITUT FRANCAIS DU PETROLE (FR) | 2006-04-06 | — | — | US | disclosed |
| US-20040260112-A1 | Method of producing nitrile compounds | BASSET JEAN-MARIE (FR) | 2004-12-23 | — | — | US | disclosed |
| US-20030225303-A1 | Hydroformylation process employing a cobalt-based catalyst in a non-aqueous liquid with improved catalyst recycling | INSTITUT FRANCAIS DU PETROLE (FR) | 2003-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070179302-A1 | PROCESS FOR CO-PRODUCING OLEFINS AND DIESTERS OR DIACIDS BY HOMOMETHATHESIS OF UNSATURATED FATS IN NON-AQUEOUS IONIC LIQUIDS | FADS2, SCD, FADS1 | CA1 1638/4885CA2 3184/4885EEF2K 3284/4885 |
| US-20030225303-A1 | Hydroformylation process employing a cobalt-based catalyst in a non-aqueous liquid with improved catalyst recycling | NUDT1, AP2S1, SRSF1 | CA1 423/4885CA2 925/4885EEF2K 255/4885 |
| US-20060079704-A1 | Process for co-producing olefins and esters by ethenolysis of unsaturated fats in non-aqueous ionic liquids | ELOVL3, ELOVL1, FASN | CA1 2957/4885CA2 3537/4885EEF2K 428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.